Jennifer Sobol, DO
Urology · West Bloomfield, MINPI 1558326926
Payments from drug & device makers
Across 521 payments — averaging $218.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$69K
- Ironwood Pharmaceuticals, Inc$20K
- GSK$13K
- Medtronic$6K
- Axonics, Inc.$1K
- Coloplast$557
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $69,385 |
| Ironwood Pharmaceuticals, Inc | 9 | $20,164 |
| GSK | 6 | $13,311 |
| Medtronic(2 entities) | 236 | $6,433 |
| Axonics, Inc. | 55 | $1,459 |
| Coloplast | 15 | $557 |
| Astellas Pharma US Inc | 12 | $265 |
| Merck | 8 | $218 |
| Sumitomo Pharma America, Inc. | 14 | $214 |
| Boston Scientific | 5 | $194 |
| Myriad Genetic Laboratories, Inc. | 2 | $128 |
| Pfizer | 1 | $125 |
| Bayer | 5 | $116 |
| Johnson & Johnson | 5 | $98 |
| Progenics Pharmaceuticals, Inc. | 4 | $94 |
| Olympus America Inc. | 4 | $86 |
| Urogen Pharma, Inc. | 4 | $83 |
| Forte Bio-pharma LLC | 5 | $81 |
| Avation Medical, Inc. | 3 | $75 |
| AstraZeneca | 3 | $72 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $60 |
| Dendreon Pharmaceuticals LLC | 2 | $47 |
| 180 Medical, Inc. | 3 | $46 |
| Angiodynamics, Inc. | 2 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Photocure Inc | 1 | $24 |
| Calyxo, Inc. | 1 | $22 |
| Blue Earth Diagnostics | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $11 |
How this compares
$113,593 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in West Bloomfield
- Jason HafronWest Bloomfield$9.9M
- Gregory OldfordWest Bloomfield$28K
- Brian SeifmanWest Bloomfield$21K
- Ashok ReddySterling Heights$4.9M
- Kenneth KernenTroy$3.4M
- James PeabodyDetroit$2.1M
- William RobertsAnn Arbor$973K
- Adam GadzinskiRoyal Oak$727K
- William JohnstonLivonia$675K
- Kenneth PetersRoyal Oak$590K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.